KCGI to sell Osstem stake to Unison-MBK consortium
The headquarters of Osstem Implant located in western Seoul / NewsisBy Anna J. Park The Korea Corporate Governance Improvement (KCGI) has decided to sell its 6.92 percent stake in Osstem Implant during a tender offer launched late last month by a consortium made up of Unison Capital Korea and MBK Partners, according to the activist fund. The tender offer is scheduled to last through Feb. 24.KCGI said Friday that the decision to accept the tender offer is to respect a good faith principle for its fund investors. It means that under the principle, the activist fund company needs to perform actions that guarantee the best interests of its investors. As the private equity giants' consortium decided to pay 190,000 won ($150) per share during the tender offer, the activist fund company could reap an internal rate of return (IRR) of over 150 percent, if it responds to the offer.The fund company worried that if it does not respond to the tender offer, the stocks held by the investment company might face a lower price than the tender offer price per share, during the remaining procedure of a
